Literature DB >> 8706452

Closed-loop control of airway occlusion pressure at 0.1 second (P0.1) applied to pressure-support ventilation: algorithm and application in intubated patients.

G A Iotti1, J X Brunner, A Braschi, T Laubscher, M C Olivei, A Palo, C Galbusera, A Comelli.   

Abstract

OBJECTIVE: Airway occlusion pressure at 0.1 sec (P0.1) is an index of respiratory center output. During pressure-support ventilation, P0.1 correlates with the mechanical output of the inspiratory muscles and has an inverse relationship with the amount of pressure-support ventilation. Based on these observations, we designed a closed-loop control which, by automatically adjusting pressure-support ventilation, stabilizes P0.1, and hence patient inspiratory activity, at a desired target. The purpose of the study was to demonstrate the feasibility of the method, rather than its efficacy or even its influence on patient outcome.
DESIGN: Prospective, randomized trial.
SETTING: A general intensive care unit of a university hospital in Italy. PATIENTS: Eight stable patients intubated and ventilated with pressure-support ventilation for acute respiratory failure.
INTERVENTIONS: Patients were transiently connected to a computer-controlled ventilator on which the algorithm for closed-loop control was implemented. The closed-loop control was based on breath by breath measurement of P0.1, and on comparison with a target set by the user. When actual P0.1 proved to be higher than the target value, the P0.1 controller automatically increased pressure-support ventilation, and decreased it when P0.1 proved to be lower than the target value. For safety, a volume controller was also implemented. Four P0.1 targets (1.5, 2.5, 3.5, and 4.5 cm H2O) were applied at random for 15 mins each.
MEASUREMENTS AND MAIN RESULTS: The closed-loop algorithm was able to control P0.1, with a difference from the set targets of 0.59 +/- 0.27 (SD) cm H2O.
CONCLUSIONS: The study shows that P0.1 can be automatically controlled by pressure-support ventilation adjustments with a computer. Inspiratory activity can thus be stabilized at a level prescribed by the physician.

Entities:  

Mesh:

Year:  1996        PMID: 8706452     DOI: 10.1097/00003246-199605000-00008

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  7 in total

1.  The airway occlusion pressure (P0.1) to monitor respiratory drive during mechanical ventilation: increasing awareness of a not-so-new problem.

Authors:  Irene Telias; Felipe Damiani; Laurent Brochard
Journal:  Intensive Care Med       Date:  2018-01-19       Impact factor: 17.440

2.  Changes in occlusion pressure (P0.1) and breathing pattern during pressure support ventilation.

Authors:  P F Perrigault; Y H Pouzeratte; S Jaber; X J Capdevila; M Hayot; G Boccara; M Ramonatxo; P Colson
Journal:  Thorax       Date:  1999-02       Impact factor: 9.139

3.  Clinical evaluation of a computer-controlled pressure support mode.

Authors:  M Dojat; A Harf; D Touchard; F Lemaire; L Brochard
Journal:  Am J Respir Crit Care Med       Date:  2000-04       Impact factor: 21.405

4.  Measurement of occlusion pressures in critically ill patients.

Authors: 
Journal:  Crit Care       Date:  1997       Impact factor: 9.097

5.  A Critical Review of Mechanical Ventilation Virtual Simulators: Is It Time to Use Them?

Authors:  Juliana Arcanjo Lino; Gabriela Carvalho Gomes; Nancy Delma Silva Vega Canjura Sousa; Andrea K Carvalho; Marcelo Emanoel Bezerra Diniz; Antonio Brazil Viana Junior; Marcelo Alcantara Holanda
Journal:  JMIR Med Educ       Date:  2016-06-14

Review 6.  Monitoring Patient Respiratory Effort During Mechanical Ventilation: Lung and Diaphragm-Protective Ventilation.

Authors:  Michele Bertoni; Savino Spadaro; Ewan C Goligher
Journal:  Crit Care       Date:  2020-03-24       Impact factor: 9.097

Review 7.  The dawn of physiological closed-loop ventilation-a review.

Authors:  Philip von Platen; Anake Pomprapa; Burkhard Lachmann; Steffen Leonhardt
Journal:  Crit Care       Date:  2020-03-29       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.